Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has announced the acceptance of a drug registration application for one of its subsidiaries. This announcement, made in accordance with Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, was published on the Shanghai Stock Exchange's website. The board of directors guarantees the announcement's accuracy and advises investors to consider the inherent risks due to the pharmaceutical industry's unique characteristics, such as market demand, competition, and sales channels, which can affect the sales performance of pharmaceutical products post-launch.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.